Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 290

Results For "IMI"

3833 News Found

Granules India chooses Veeam to protect digital business
Digitisation | May 30, 2022

Granules India chooses Veeam to protect digital business

Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours


OS-SiA digital pathology scanner developed by OptraSCAN granted US patent
Biotech | May 30, 2022

OS-SiA digital pathology scanner developed by OptraSCAN granted US patent

OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights


USFDA approves two Opdivo-based regimens
Biotech | May 29, 2022

USFDA approves two Opdivo-based regimens

Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers


All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022
Healthcare | May 29, 2022

All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022

The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds


MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
Biotech | May 29, 2022

MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData

RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised


Bempedoic acid market in India will get crowded soon:  GlobalData
News | May 27, 2022

Bempedoic acid market in India will get crowded soon: GlobalData

Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe


Next-gen immunotherapy drug shows promise in several advanced-stage cancers
Biotech | May 27, 2022

Next-gen immunotherapy drug shows promise in several advanced-stage cancers

Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells


New data demonstrate clinical benefit of Roche’s glofitamab
Biotech | May 27, 2022

New data demonstrate clinical benefit of Roche’s glofitamab

Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma


A.Menarini expands its dermatology portfolio with the launch of Solar D
Healthcare | May 27, 2022

A.Menarini expands its dermatology portfolio with the launch of Solar D

The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D


DFE Pharma opens its new Center of Excellence in Hyderabad, India
News | May 27, 2022

DFE Pharma opens its new Center of Excellence in Hyderabad, India

The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs